The Journal of Organic Chemistry
Note
Fullerenol 2d. According to the general procedure, the reaction of
C60 (36.0 mg, 0.05 mmol) with 1d (318 μL, 2.5 mmol) and
Fe(ClO4)3·6H2O (69.0 mg, 0.15 mmol) for 20 min afforded first a
trace amount of recovered C60 and then 2d (10.6 mg, 24%) as an
amorphous black solid: mp >300 °C; 1H NMR (300 MHz, CS2/
DMSO-d6) δ 8.63 (s, 1H), 8.41 (d, J = 8.7 Hz, 2H), 7.59 (d, J = 8.7
Hz, 2H); 13C NMR (75 MHz, CS2/DMSO-d6 with Cr(acac)3 as
relaxation reagent) (all 2C unless indicated) δ 164.19 (1C, CO),
152.33, 148.26, 147.58 (1C), 147.51 (1C), 145.53, 145.46, 145.21,
145.15 (4C), 144.77 (4C), 144.53, 144.18 (4C), 144.06 (4C), 143.79,
141.77, 141.64, 141.49, 141.34 (4C), 140.75, 140.57 (4C), 140.40,
138.67 (1C, aryl C), 138.43, 138.05, 137.98, 135.40, 131.12 (aryl C),
128.32 (1C, aryl C), 128.03 (aryl C), 87.94 (1C, sp3-C of C60), 83.16
(1C, sp3-C of C60); FT-IR ν/cm−1 (KBr) 2923, 1708, 1594, 1428,
1401, 1270, 1091, 1041, 1016, 992, 847, 754, 527; UV−vis (CHCl3)
λmax/nm (log ε) 256 (5.12), 317 (4.65), 416 (3.85), 685 (3.42);
MALDI FT-ICR MS m/z calcd for C67H535ClO3 [M−] 891.9927,
found 891.9932.
Fullerenol 2e. According to the general procedure, the reaction of
C60 (36.0 mg, 0.05 mmol) with 1e (317 μL, 2.5 mmol) and
Fe(ClO4)3·6H2O (23.0 mg, 0.05 mmol) for 20 min afforded first
recovered C60 (23.1 mg, 64%) and then 2e (10.6 mg, 24%) as an
amorphous black solid: mp >300 °C; 1H NMR (300 MHz, CS2/
CDCl3) δ 8.42 (d, J = 8.1 Hz, 1H), 7.65−7.49 (m, 3H), 5.14 (s, 1H);
13C NMR (75 MHz, CS2/CDCl3 with Cr(acac)3 as relaxation reagent)
(all 2C unless indicated) δ 167.89 (1C, CO), 150.82, 148.66 (1C),
148.56 (1C), 147.23, 146.55 (4C), 146.29, 146.20 (4C), 146.00,
145.49, 145.25 (4C), 145.00, 144.90, 144.63 (4C), 142.65 (4C),
142.53, 142.35, 142.27, 141.59 (4C), 141.38 (4C), 139.72, 139.25,
138.63, 136.54, 134.98 (1C, aryl C), 133.64 (1C, aryl C), 132.66 (1C,
aryl C), 131.54 (1C, aryl C), 128.95 (1C, aryl C), 126.91 (1C, aryl C),
89.58 (1C, sp3-C of C60), 84.96 (1C, sp3-C of C60); FT-IR ν/cm−1
(KBr) 2922, 1701, 1590, 1467, 1431, 1357, 1291, 1244, 1102, 1041,
988, 743, 525; UV−vis (CHCl3) λmax/nm (log ε) 256 (5.04), 317
(4.60), 416 (3.75), 685 (3.36); MALDI FT-ICR MS m/z calcd for
C67H535ClO3 [M−] 891.9927, found 891.9921.
ASSOCIATED CONTENT
■
S
* Supporting Information
1H NMR and 13C NMR spectra of products 2a−f and 3. This
material is available free of charge via the Internet at http://
AUTHOR INFORMATION
Corresponding Author
Notes
■
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
■
We are grateful for financial support from the National Natural
Science Foundation of China (Nos. 21132007, 20972145,
21102041), National Basic Research Program of China
(2011CB921402), and Scientific Research Foundation of
Education Commission of Hubei Province (Q20120113).
REFERENCES
■
(1) For selected recent reviews, see: (a) Giacalone, F.; Martín, N.
Chem. Rev. 2006, 106, 5136. (b) Matsuo, Y.; Nakamura, E. Chem. Rev.
2008, 108, 3016. (c) Murata, M.; Murata, Y.; Komatsu, K. Chem.
Commun. 2008, 6083.
(2) For an example, see: Lu, L.-H.; Lee, Y.-T.; Chen, H.-W.; Chiang,
L. Y.; Huang, H.-C. Br. J. Pharmacol. 1998, 123, 1097.
(3) Chiang, L. Y.; Upasani, R. B.; Swirczewski, J. W. J. Am. Chem. Soc.
1992, 114, 10154.
(4) (a) Chiang, L. Y.; Swirczewski, J. W.; Hsu, C. S.; Chowdhury, S.
K.; Cameron, S.; Creegan, K. J. Chem. Soc., Chem. Commun. 1992,
1791. (b) Chiang, L. Y.; Upasani, R. B.; Swirczewski, J. W.; Soled, S. J.
Am. Chem. Soc. 1993, 115, 5453.
(5) Li, J.; Takeuchi, A.; Ozawa, M.; Li, X.; Saigo, K.; Kitazawa, K. J.
Chem. Soc., Chem. Commun. 1993, 1784.
Fullerenol 2f and C60-Fused Lactone 3. According to the
general procedure, the reaction of C60 (36.0 mg, 0.05 mmol) with 1f
(416 mg, 2.5 mmol) and Fe(ClO4)3·6H2O (69.0 mg, 0.15 mmol) for
20 min afforded first recovered C60 (18.8 mg, 52%), then 3 (11.2 mg,
26%) and 2f (7.4 mg, 17%). 2f: amorphous black solid; mp >300 °C;
1H NMR (300 MHz, CS2/CDCl3) δ 8.17 (d, J = 15.9 Hz, 1H), 7.69−
7.66 (m, 2H), 7.46−7.43 (m, 3H), 6.94 (d, J = 15.9 Hz, 1H), 5.18 (s,
1H); 13C NMR (75 MHz, CS2/CDCl3 with Cr(acac)3 as relaxation
reagent) (all 2C unless indicated) δ 169.49 (1C, CO), 151.04,
148.46 (1C), 148.37 (1C), 147.62 (1C, CH-Ph), 147.51, 146.36 (4C),
146.07, 146.00 (4C), 145.80, 145.34, 145.06 (4C), 144.97, 144.76,
144.51 (4C), 142.48 (4C), 142.35, 142.20, 142.11, 141.42, 141.38,
141.25 (4C), 139.54, 139.02, 138.37, 136.28, 133.90 (1C, aryl C),
130.87 (1C, aryl C), 128.93 (aryl C), 128.42 (aryl C), 116.81 (1C,
CH−CO), 88.74 (1C, sp3-C of C60), 84.97 (1C, sp3-C of C60); FT-IR
ν/cm−1 (KBr) 2920, 1696, 1632, 1447, 1432, 1329, 1311, 1269, 1202,
1169, 1147, 1101, 1035, 1013, 976, 918, 860, 755, 708, 598, 575, 526;
UV−vis (CHCl3) λmax/nm (log ε) 256 (4.94), 318 (4.68), 418 (3.50),
688 (2.34); MALDI FT-ICR MS m/z calcd for C69H8O3 [M−]
884.0473, found 884.0475. 3: amorphous black solid; mp >300 °C; 1H
NMR (300 MHz, CS2/CDCl3) δ 8.72 (s, 1H), 7.36−7.32 (m, 2H),
7.19−7.16 (m, 3H); 13C NMR (75 MHz, CS2/CDCl3 with Cr(acac)3
as relaxation reagent) (all 2C unless indicated) δ 168.72 (1C, CO),
151.17, 147.95 (1C), 147.42 (1C), 146.39, 146.26 (1C, CH-Ph),
145.99 (8C), 145.56, 145.48, 145.33, 145.18, 145.09, 145.03, 144.51,
144.33 (4C), 142.61 (6C), 142.14 (4C), 142.04, 141.83, 141.16,
140.98, 139.84, 138.28, 137.16, 135.17, 132.62 (1C, aryl C), 128.83
(1C, aryl C), 128.26 (aryl C), 128.15 (aryl C), 127.87 (1C, CH−CO),
96.63 (1C, sp3-C of C60), 64.90 (1C, sp3-C of C60); FT-IR ν/cm−1
(KBr) 2921, 1768, 1506, 1435, 1238, 1194, 1164, 998, 970, 967, 741,
694, 595, 575, 526; UV−vis (CHCl3) λmax/nm (log ε) 256 (4.97), 317
(4.62), 416 (3.50), 682 (2.28); MALDI FT-ICR MS m/z calcd for
C69H6O2 [M−] 866.0368, found 866.0365.
(6) (a) Chiang, L. Y.; Wang, L.-Y.; Swirczewski, J. W.; Soled, S.;
Cameron, S. J. Org. Chem. 1994, 59, 3960. (b) Chen, B.-H.; Huang, J.-
P.; Wang, L.-Y.; Shiea, J.; Chen, T.-L.; Chiang, L. Y. J. Chem. Soc.,
Perkin Trans. 1 1998, 1171.
(7) Chiang, L. Y.; Bhonsle, J. B.; Wang, L.-Y.; Shu, S. F.; Chang, T.
M.; Hwu, J. R. Tetrahedron 1996, 52, 4963.
(8) Schneider, N. S.; Darwish, A. D.; Kroto, H. W.; Taylor, R.;
Walton, D. R. M. J. Chem. Soc., Chem. Commun. 1994, 463.
(9) Birkett, P. R.; Avent, A. G.; Darwish, A. D.; Kroto, H. W.; Taylor,
R.; Walton, D. R. M. J. Chem. Soc., Chem. Commun. 1996, 10, 1231.
(10) Al-Matar, H.; Abdul-Sada, A. K.; Avent, A. G.; Fowler, P. W.;
Hitchcock, P. B.; Rogers, K. M.; Taylor, R. J. Chem. Soc., Perkin Trans.
2 2002, 53.
(11) Al-Matar, H.; Hitchcock, P. B.; Avent, A. G.; Taylor, R. Chem.
Commun. 2000, 35, 1071.
(12) For selected examples, see: (a) Xiao, Z.; Yao, J.; Yang, D.; Wang,
F.; Huang, S.; Gan, L.; Jia, Z.; Jiang, Z.; Yang, X.; Zheng, B.; Yuan, G.;
Zhang, S.; Wang, Z. J. Am. Chem. Soc. 2007, 129, 16149. (b) Zhang,
G.; Liu, Y.; Liang, D.; Gan, L.; Li, Y. Angew. Chem., Int. Ed. 2010, 49,
5293.
(13) Meier, M. S.; Kiegiel, J. Org. Lett. 2001, 3, 1717.
(14) Yoshida, M.; Morinaga, Y.; Iyoda, M.; Kikuchi, K.; Ikemodo, I.;
Achiba, Y. Tetrahedron Lett. 1993, 34, 7629.
(15) Irngartinger, H.; Weber, A. Tetrahedron Lett. 1997, 38, 2075.
(16) Kitagawa, T.; Sakamoto, H.; Takeuchi, K. J. Am. Chem. Soc.
1999, 121, 4298.
(17) Tajima, Y.; Hara, T.; Honma, T.; Matsumoto, S.; Takeuchi, K.
Org. Lett. 2006, 8, 3203.
(18) Wang, G.-W.; Li, F.-B.; Xu, Y. J. Org. Chem. 2007, 72, 4774.
(19) Tuktarov, A. R.; Akhmetov, A. R.; Pudas, M.; Ibragimov, A. G.;
Dzhemilev, U. M. Tetrahedron Lett. 2008, 49, 808.
(20) Wang, G.-W.; Lu, Y.-M.; Chen, Z.-X. Org. Lett. 2009, 11, 1507.
6646
dx.doi.org/10.1021/jo301202g | J. Org. Chem. 2012, 77, 6643−6647